These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions. Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the treatment of autoimmune uveitis with prednisone and with cyclophosphamide and azathioprine]. Flores M; Gudiño Pérez R; Ríos Prado R; Almedia Arvizu VM; Castrejón Vázquez MI; Ocampo AA Rev Alerg Mex; 2001; 48(3):75-9. PubMed ID: 11554127 [TBL] [Abstract][Full Text] [Related]
10. Treatment of severe refractory uveitis with intravenous cyclophosphamide. Rosenbaum JT J Rheumatol; 1994 Jan; 21(1):123-5. PubMed ID: 8151566 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome]. Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191 [TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects. Tognon S; Graziani G; Marcolongo R Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463 [TBL] [Abstract][Full Text] [Related]
14. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Branten AJ; Wetzels JF Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653 [TBL] [Abstract][Full Text] [Related]
15. Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment. Faedda R; Pirisi M; Satta A; Bosincu L; Bartoli E Clin Pharmacol Ther; 1996 Nov; 60(5):576-81. PubMed ID: 8941031 [TBL] [Abstract][Full Text] [Related]
16. [Endogenous uveitis]. Ríhová E; Havlíková M; Michalová K; Boguszaková J; Stara J; Poch T Cesk Oftalmol; 1994 Apr; 50 Suppl():S32-40. PubMed ID: 8194118 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571 [TBL] [Abstract][Full Text] [Related]
19. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. Hofstra JM; Wetzels JF Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961 [TBL] [Abstract][Full Text] [Related]
20. [Cyclophosphamide in the treatment of immune hemocytopenias]. Sakalová A; Hrubisko M Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):559-64. PubMed ID: 54306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]